Janiczek Wealth Management’s Acceleron Pharma XLRN Stock Holding History

Janiczek Wealth Management’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-85	Closed	-$15K	–	1123
2021 Q3	$15K	Sell	85 -6	-7%	-$785	0.01%	508
2021 Q2	$11K	Sell	91 -5	-5%	-$631	﹤0.01%	545
2021 Q1	$13K	Sell	96 -16	-14%	-$2.07K	0.01%	481
2020 Q4	$14K	Buy	+112	New	+$13.1K	0.01%	413

Janiczek Wealth Management's XLRN Position: Q4 2021 in Review

Janiczek Wealth Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 85 shares — an estimated $15K sold.

Janiczek Wealth Management first reported a position in XLRN in Q4 2020 and held it in 4 quarters. The position peaked at $15K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Janiczek Wealth Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Janiczek Wealth Management sold 85 Acceleron Pharma shares in Q4 2021, an estimated $15K.
Janiczek Wealth Management first reported a position in Acceleron Pharma in Q4 2020 and held it in 4 quarters.
Janiczek Wealth Management's Acceleron Pharma position peaked at $15K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Janiczek Wealth Management's 13F filing for Q4 2021, filed 2 Feb 2022.